Ronald E Blaylock insider trades

Open-market stock purchases and sales by Ronald E Blaylock, Director at Pfizer Inc, from SEC Form 4 filings since Jan 5, 2010.

Track record: 38% of 8 scored buys are up 5% or more since purchase, averaging -7%.

Recent trades

DateStockTradeValue
Aug 5, 2026PFE Pfizer IncBought$999K
Jun 3, 2026WRB Berkley W R CorpBought (not open market)—
Apr 23, 2026PFE Pfizer IncBought (not open market)$205K

Companies traded

  • PFE Pfizer Inc: 7 buys, last Aug 5, 2026
  • WRB Berkley W R Corp: 2 sales, last Jun 3, 2026
  • KMX CarMax Inc: 1 buy, 7 sales, last Jul 1, 2024
  • ADV Advantage Solutions Inc: other filings, last May 25, 2022
  • ROIA/ROIAK Urban ONE, Inc: 3 sales, last Jun 15, 2018

Get free alerts when Ronald E Blaylock files a new trade →